News Source: China Money Network.
Chinese biopharmaceutical company Shanghai Junshi Biosciences Co. has filed for a US$414 million initial public offering in Hong Kong, according to a security filing released today.
Chinese Biopharmaceutical Firm Junshi Biosciences Targets $414M IPO In Hong Kong appeared first on Continue Reading the Entire Article Here >>
This news article comes via China Money Network, who is the copyright owner of this information and news. FintekAsia.com has licensed the rights to this article and any republication or re-distribution in whole or in part of this content is strictly prohibited without the express consent of
